ArticleCommunications medicine2025

Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history.

Sho Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.